Learn / CRSP
NASDAQ: CRSP
CRISPR Therapeutics AG (CRSP) stock, explained like you're 5
CRISPR Therapeutics AG trades on the Nasdaq under the ticker CRSP. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 5.2 billion dollars.
- Ticker
- CRSP
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 5.2 billion dollars
Is CRISPR Therapeutics AG a small, medium or large cap company?
No. CRISPR Therapeutics AG is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How CRISPR Therapeutics AG makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CRSP stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- CRSP Stock Climbs After Hours As CRISPR Maps Busy Second Half Pipeline After Upbeat Q2 (Stocktwits)
- CRISPR Therapeutics (CRSP) Stock Looks Rich On Upcoming CTX310 Trial Data (Yahoo Finance)
- CRISPR Therapeutics (CRSP) Stock Dropped, So What Is Driving Attention Now? (Simply Wall Street)
- Tax withholding required CRISPR Therapeutics (CRSP) counsel to sell shares at $49.26 each. (Stock Titan)
- CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock (MarketBeat)
Follow CRSP in your daily brief
Each trading day at 5 PM ET we post what happened to CRISPR Therapeutics AG and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CRSP
Questions about CRISPR Therapeutics AG stock
What does CRISPR Therapeutics AG do?
CRISPR Therapeutics AG trades on the Nasdaq under the ticker CRSP. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 5.2 billion dollars.
What is the ticker symbol for CRISPR Therapeutics AG?
CRISPR Therapeutics AG trades under the ticker CRSP on the Nasdaq.
What is CRISPR Therapeutics AG's market cap?
CRISPR Therapeutics AG is a mid cap stock with a market cap of about 5.2 billion dollars.
How does CRISPR Therapeutics AG make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CRSP stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CRSP stock every day?
Add CRSP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.